Hu J J, Zheng M J, Chen Y, Yu L Y, Yang H
Department of Otorhinolaryngology Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
West China School of Stomatology, Sichuan University, Chengdu 610041, China.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Aug 7;53(8):635-639. doi: 10.3760/cma.j.issn.1673-0860.2018.08.017.
The treatment for laryngopharyngeal reflux diseases consist of general treatment, medical therapy and surgical treatment, among which, drug therapy is still the main effective way. Proton pump inhibitor is adopted as the first drug for patients with laryngopharyngeal reflux disease only caused by acid reflux. With standardized treatment, the majority of symptoms in laryngopharyngeal reflux disease could be alleviated effectively. PPI therapy, while seeming logical, is less useful in patients with reflux hypersensitivity, weak acid or non acid reflux, neuropsychic factors and gastroesophageal reflux disease. This article aims to investigate bewilderment and challenge faced by clinicians when managing adult laryngology reflux disease with medical therapy.
喉咽反流疾病的治疗包括一般治疗、药物治疗和手术治疗,其中药物治疗仍是主要的有效方法。质子泵抑制剂被用作仅由酸反流引起的喉咽反流疾病患者的首选药物。通过规范化治疗,喉咽反流疾病的大多数症状可得到有效缓解。质子泵抑制剂治疗虽然看似合理,但在反流高敏、弱酸或非酸反流、神经精神因素及胃食管反流病患者中作用较小。本文旨在探讨临床医生在采用药物治疗成人喉科反流疾病时所面临的困惑与挑战。